CITES is a Venture builder, supported by a 24MU$S VC fund that co-creates, along founders, scientific-based startups. With a deep tech focus, CITES invests at the startups’ formation stage, through seed and series A. With over 30MU$S in assets under management, CITES is uniquely equipped, and positioned, to enable the development of scientific-based entrepreneurs, and the deep tech ecosystem in the region.
Besides the capital investments, CITES supports its portfolio companies by providing office space, with fully equipped labs, team formation resources and trainings, hands-on technology expertise, IP and product development guidance, and insights for business strategy, networking, and fundraising processes, among others.
Founded in 2013, initially backed by Sancor Seguros Group – the leading insurance company in Argentina, CITES has been a pioneer in the deep tech venture building space. In 2017, CITES was awarded the Scientific Accelerator Program Franchise from SePyME, and in 2020, listed its first financial trust (CITES I), in the Argentine stock exchange – the first listed VC vehicle in the region.
CITES invests in deep tech opportunities, spanning multiple industries.
Company Details
- Employees
- 15
- Address
- Av. Belgrano 758, Sunchales,santa Fe 2322,argentina
- Phone
- +54 3493 42-0900
- in****@****gss.com
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- cites-gss.com
- Keywords
- as Head of the Hi-Tech Financing Department at the Israel Innovation Authority. For decades.
- HQ
- Sunchales, Santa Fe
Cites Questions
Cites's helpline number is +54 3493 42-0900
Cites's website is cites-gss.com
Cites's LinkedIn profile is https://ar.linkedin.com/company/cites
Cites has
15 employees.
View email and phone details for 15
employees at Cites.
Cites's industry is
Venture Capital and Private Equity Principals
Cites's top competitors are
Aceleradora Litoral,
Kamay Ventures,
Sf500,
Embarca,
Sancor Seguros Ventures,
Gridx,
Gridex,
Draper Cygnus,
Giraffe Bio,
Epiliquid.
Cites's support email address is info@cites-gss.com
Cites's categories are Venture Capital and Private Equity Principals
